ARTICLE | Company News
BioQuest, Biovector deal
April 17, 2000 7:00 AM UTC
The companies will evaluate the development of an HIV vaccine that combines HIVX's cocktail of HIV protein envelope peptides with Biovector's technology for delivering antigens in lipopeptide construc...